NCT04021589View on ClinicalTrials.gov

Chemotherapy w/wo WeiLeShu in Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 11, 2019

Primary Completion Date

October 30, 2021

Study Completion Date

October 30, 2021

Conditions
Microbial ColonizationColorectal Cancer
Interventions
DRUG

Weileshu

a probiotics products which help to rebuild homeostasis of gut microbiome

DRUG

Chemotherapy

chemotherapy

Trial Locations (1)

310006

First affiliated hospital, Zhejiang University, Hangzhou

All Listed Sponsors
lead

Zhejiang University

OTHER

NCT04021589 - Chemotherapy w/wo WeiLeShu in Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter